UK markets closed
  • NIKKEI 225

    28,508.55
    -591.83 (-2.03%)
     
  • HANG SENG

    28,621.92
    -513.81 (-1.76%)
     
  • CRUDE OIL

    61.45
    -1.22 (-1.95%)
     
  • GOLD FUTURES

    1,792.00
    +13.60 (+0.76%)
     
  • DOW

    34,082.53
    +261.23 (+0.77%)
     
  • BTC-GBP

    39,776.64
    -378.73 (-0.94%)
     
  • CMC Crypto 200

    1,278.24
    +15.28 (+1.21%)
     
  • ^IXIC

    13,891.80
    +105.54 (+0.77%)
     
  • ^FTAS

    3,935.64
    +15.59 (+0.40%)
     

Navigating the Medical Device Post-Market Maze and Challenges During COVID-19 Pandemic Online Seminar - Learn what FDA is Really Thinking on Regulation and Guidance Documents (May 13-14, 2021)

Research and Markets
·5-min read

Dublin, March 10, 2021 (GLOBE NEWSWIRE) -- The "Navigating the Medical Device Post-Market Maze and Challenges during COVID-19 Pandemic - Learn what FDA is really thinking on regulation and guidance documents" conference has been added to ResearchAndMarkets.com's offering.

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time-consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

  • How to overcome one of the biggest obstacles device manufacturers face

  • How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling, and documentation

  • How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.

  • How to conduct correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall, and key factors in implementing and maintaining compliance with the regulations and real-life experiences of FDA.

**New course materials have been added, updated content will include:

  • Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and

  • What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug, and veterinary industries can provide.

Learning Objectives:

  • Understand how to comply with complicated Complaint Handling, MDR and Recall requirements

  • Firms MDR reporting and FDA's handling of reports

  • Company preparation in the event of a Recall, recall strategy, notification letter and communicating with the FDA

  • Minimize your risk of regulatory enforcement actions

  • Assist with the creation and maintenance of effective procedures for handling complaints, reportable events and recalls

  • Understand the relationship and interaction with other quality system elements as they relate to complaints and reportable events

  • Walk-through of case examples

  • Step-By-Step guide to designing Standard Operating Systems for communicating process for firm's success

  • Discussion of FDA's New Guidance's on Risk and how it interacts with Recalls



Who Should Attend:

This course will benefit anyone in the medical device industry that handles functions involving product complaints, recalls, medical device reporting.

  • Regulatory Affairs

  • QA/QC

  • Project Managers

  • Regulatory Professional

  • Risk Managers

  • Complaint Handling Teams

  • CAPA Teams



Agenda:

Day 01 (10:00 AM - 4:00 PM EDT)

Introduction (15 mins)

Session 1

  • Complaint Handling and FDA Expectations (90 mins)

Break (15 mins)

Session 2

  • Continuation Complaint Handling and FDA Expectations (30 mins)

  • Medical Device Reporting Procedures (MDR) Regulations, Procedures, and Malfunctions (60 min)

Lunch Break (45 mins)

Session 3

  • Continuation of Medical Device Reporting Procedures (MDR) Regulations, Procedures, and Malfunctions (60 min)

  • MDR reporting by the firm, agents Voluntary Malfunction Summary Reporting (VMSR) and eMDR Discussion (30 min)

Break (15 mins)

Session 4

  • Guidance Documents Update (30mins)

  • Being Recall Ready (30mins)

  • Questions and Recap (10 mins)

Day 02 (10:00 AM - 4:00 PM EDT)

Session 1

  • Recalls, Definition and Legal Authority Overview (60 mins)

  • Corrective and Preventative Actions (CAPA) (30 mins)

Break (15 mins)

Session 2

  • Health Hazard Evaluations HHE/HRA (30 mins)

  • Elements of a Correction and Removal -- 806 Reporting (45 mins)

Lunch Break (45 mins)

Session 3

  • Developing Effective Strategies / Communicating and Negotiating with FDA (45mins)

  • Notifications Letters and Press Releases (20 mins)

  • Silent Recalls / Product Enhancements and Enforcement Actions (20 mins)

Break (10 mins)

Session 4

  • Product Retrieval (20 mins)

  • Status Reports (20 mins)

  • Effectiveness Checks Follow-up Planning (20 mins)

  • Terminating a Recall (15 mins)

  • Wrap-up (5 mins)



Speakers:

Rita Hoffman, RAC
Regs & Recall Strategies, LLC

Rita Hoffman, RAC. Managing Partner Regs & Recall Strategies, LLC .Ms. Hoffman has more than 36 years of FDA experience across the device, drug and veterinary industries. She has an intimate understanding of FDA regulatory and compliance issues from the perspective of both FDA and regulated industry. As an FDA compliance consultant, she provides clients with regulatory insight, advises on critical compliance deficiencies, performs compliance and new product audits, provides insight and guidance on recall strategies to the medical device industry, and advises on jurisdiction determinations for combination products.

Ms. Hoffman retired from the FDA in January 2011 as the Recall Branch Chief for the Center for Devices and Radiological Health (CDRH), where she was responsible for oversight and review for all medical device recalls. Ms. Hoffman held several positions including the Center for Drug Evaluation and Research (CDER) Jurisdiction Review Officer (providing guidance on drug/device product designation, combination products and co-packaging), Acting Associate Ombudsman, Small Business Liaison, and was a Policy Analyst for eight years in the Office of the Commissioner. She served as co-chair of RAPS' Baltimore/Washington Metropolitan Area Chapter for 2-terms, and in 2008 was presented with the Special Recognition Award by RAPS.



For more information about this conference visit https://www.researchandmarkets.com/r/ddo6iq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900